Tesamorelin 12mg High Dose is a synthetic form of growth hormone-releasing hormone (GHRH) that effectively stimulates the pituitary gland to produce and release growth hormone (GH). Consisting of a 44 amino acid sequence, tesamorelin specifically targets the release of GH, which subsequently increases Insulin-Like Growth Factor-1 (IGF-1) levels in the liver. Originally FDA-approved under the brand name EGRIFTA for treating HIV-associated lipodystrophy, tesamorelin has also demonstrated significant benefits in general health management related to growth hormone levels.

• Decreased Body Fat: Particularly effective in reducing visceral fat.
• Increased Muscle Mass: Promotes the growth of lean muscle tissue.
• Enhanced Physical Performance: Improves strength and energy levels.
• Improved Sleep Quality: Assists in enhancing the quality of sleep and combatting insomnia.
• Enhanced Bone Density: Supports calcium retention and improves bone density.
• Boosted Immune Function: Contributes to a healthier immune system response.
• Improved Skin Elasticity: Aids in maintaining and improving skin firmness.
• Tissue Repair: Facilitates the repair of connective tissues post-injury.

While primarily used for HIV-associated conditions, ongoing research and clinical trials continue to explore broader applications of tesamorelin in managing age-related and metabolic health issues.